Clinical Trials List
2013-04-01 - 2019-06-30
Phase III
Terminated5
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jen Jen and I Su Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Kon-Ping Lin Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ming-Kuei Lu Division of Neurology
- Hui-Chun Huang Division of Neurology
- Chung-Hsiang Liu Division of Neurology
- Wei-Shih Huang Division of Neurology
- Kang-Hsu Lin Division of Neurology
- Chon-Haw Tsai Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 謝函潔 Division of Neurology
- Chou-Ching Lin Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
202 participants
